In ovarian cancer, previous studies showed that CDKN2A, the mutations of which led to loss of growth control in ovarian cancer cells, is related to the cell cuproptosis sensitivity [9, 36], indicating that cuproptosis plays essential role in ovarian cancer. Here, CDKN2A is linked to ovarian carcinoma.